-
Survey investigates toll of cancer care crowdfunding on survivors
The financial relief of medical crowdfunding is often accompanied by feelings of shame in asking for help, a study published in the Journal of Cancer Survivorship suggests. -
UNC Rex opens new cancer center
Raleigh, N.C.-based UNC Rex Healthcare opened a new cancer center March 1. -
1 in 7 breast cancer cases overdiagnosed, Duke study finds
About 1 in 7 breast cancer cases are overdiagnosed, a study published March 1 in the Annals of Internal Medicine found. -
FDA approves new CAR-T cell therapy for multiple myeloma
The FDA approved carvykti, a new customized, cell-based treatment from Johnson & Johnson, for the treatment of multiple myeloma, Johnson & Johnson said Feb. 28. -
Vanderbilt-Ingram Cancer Center names director
Vanderbilt-Ingram Cancer Center in Nashville, Tenn., has selected Ben Ho Park, MD, PhD, as its new director. -
Yale Cancer Center names Conclave award winners
Yale Cancer Center named its annual Conclave awardees in honor of their outstanding contributions to cancer care and research. -
'Wonder drug' metformin not a treatment for all cancer types, researchers caution
Metformin, a drug traditionally prescribed for diabetes but recently used in clinical settings as a cancer treatment, shows "great promise" but can have negative consequences in the treatment of some cancer types, researchers at the University of Waterloo in Canada said Feb. 28. -
UC San Diego Health using sound waves as alternative prostate cancer treatment
Researchers at the University of California San Diego Health are the first in the county to employ high-intensity, focused ultrasound as a minimally invasive prostate cancer treatment, the system said Feb. 24. -
4 recent moves from the American Cancer Society
Here are four announcements from the American Cancer Society reported by Becker's since Feb. 11: -
4 schools share $16M to build cancer equity research centers
The American Cancer Society awarded over $16 million in grants to establish cancer health equity research centers at minority-serving institutions of higher learning across the country, the organization said Feb. 24. -
Hoag selects melanoma program director
Newport Beach, Calif.-based Hoag Memorial Hospital Presbyterian has selected Thomas Wang, MD, PhD, to serve as medical director of its melanoma/advanced skin cancer program. -
City of Hope receives $4.9M stem cell research grant
Los Angeles-based City of Hope was awarded a $4.9 million grant for its department of stem cell biology and regenerative medicine, the cancer research group said Feb. 22. -
Atlantic Health System taps new hematology director
Morristown, N.J.-based Atlantic Health System named Mohamad Cherry, MD, medical director of its hematology and cellular therapy programs, it said Feb. 23. -
Yale, National Brain Tumor Society launch research consortium
Yale Cancer Center is partnering with the National Brain Tumor Society to launch a flagship research initiative focused on DNA damage, the cancer center said Feb. 22. -
Karmanos Cancer Institute to pilot virtual platform
The Barbara Ann Karmanos Cancer Institute in Detroit is collaborating with Lifeguard Health Networks to pilot a digital care platform for cancer patients. -
6 oncologists on the move
These six oncologists joined new practices or received new appointments over the last few weeks. -
9 ways to get screening rates to pre-pandemic levels, per American Cancer Society
The American Cancer Society's National Consortium for Cancer Screening and Care outlined nine recommendations to bring screening rates back to pre-pandemic levels in a Feb. 16 report. -
4 recent moves from MD Anderson
Here are five moves reported by Becker's about the University of Texas MD Anderson Cancer Center since Jan. 10: -
Phase 3 trial results promising for antibody drug treating HER2 breast cancer type
AstraZeneca and Daiichi Sankyo's Enhertu breast cancer drug significantly helped patients with HER2-low metastatic breast cancer in its phase 3 clinical trial, AstraZeneca said Feb. 21. -
Yale Cancer Center adds $1.5M to hematology fellowship
Yale Cancer Center invested $1.5 million to improve its hematology/oncology fellowship program, it said Feb. 18.
Page 44 of 50